The antihomotoxic protocol for chronic sinusitis combines local mucosal support of the nasal passages with regeneration of the respiratory mucous membranes and constitutional drainage. The aim is to support the sinus terrain and mucosal function rather than simply to decongest.
This reference outlines the rationale, the three featured remedies and their roles, how the protocol is structured, and the administration and safety considerations.
The short version: Euphorbium compositum supports the nasal mucosa locally, Mucosa compositum aids mucous-membrane regeneration and Naso-Heel addresses the rhinosinus picture, combined for chronic sinusitis.
Rationale: terrain and mucosa, not just decongestion
Chronic sinusitis reflects a persistently disturbed mucosal terrain rather than a single acute event. The antihomotoxic approach therefore pairs local support of the nasal mucosa with deeper regeneration of the respiratory mucous membranes, on the reasoning that durable improvement follows restored mucosal function.
Constitutional and drainage support underpins the local work, addressing the wider terrain that predisposes to recurrence.
The remedies and their roles
Three preparations address the sinus at complementary levels.
- Euphorbium compositum drops provide local support of the nasal mucosa and the upper respiratory terrain.
- Mucosa compositum ampoules support regeneration of the respiratory mucous membranes as the deeper organ component.
- Naso-Heel addresses the rhinosinus symptom picture, including secretion and congestion.
Protocol structure and sequencing
Local and symptomatic support with Euphorbium compositum and Naso-Heel is generally run consistently, while Mucosa compositum is used intermittently as the mucous-membrane regeneration component that gives the protocol its depth.
In line with antihomotoxic practice, drainage of the matrix and lymph is often addressed alongside, so that the local mucosal work is supported by an open constitutional terrain. Courses for chronic presentations are sustained over weeks.
Administration and practical notes
Euphorbium compositum is available for nasal and oral use and Naso-Heel as an oral preparation, while Mucosa compositum ampoules are practitioner-administered by injection or, where appropriate, taken orally. Follow manufacturer directions for route, frequency and duration; do not assume fixed numeric dosing.
Reassess if fever, severe facial pain or purulent, worsening symptoms suggest acute bacterial sinusitis requiring conventional evaluation.
Combining and cautions
This protocol supports the chronic terrain and is not a treatment for acute bacterial sinusitis or complications, which require medical assessment. Observe known hypersensitivity to constituents, follow manufacturer cautions in pregnancy, and integrate with drainage and, where indicated, allergy management. Injectable use is confined to trained practitioners.
Your natural toolkit — and which to reach for
Remedies referenced in this protocol. Mucosa compositum is a practitioner-administered injectable; the others are for nasal or oral use.
Euphorbium Compositum — local support of the nasal mucosa and upper respiratory terrain.
Mucosa Compositum Ampoules — regeneration support for the respiratory mucous membranes.
Naso-Heel — addresses the rhinosinus symptom picture of secretion and congestion.
Featured products
Explore the full United Remedies range — blending homeopathy from Heel, Guna and Sanum with Weleda’s plant-based topicals and Zooki’s liposomal supplements.
Practitioner FAQ
How does this protocol differ from a decongestant approach?
Rather than simply reducing congestion, it pairs local mucosal support with deeper regeneration of the respiratory mucous membranes and constitutional drainage, aiming to support restored mucosal function and the terrain that predisposes to recurrence.
What is the role of Mucosa compositum specifically?
It provides the mucous-membrane regeneration component that gives the protocol its depth, used intermittently while the local and symptomatic preparations run more consistently. It is a practitioner-administered organ preparation within the wider plan.
When should a patient be referred for conventional assessment?
Fever, severe facial pain, or purulent and worsening symptoms may indicate acute bacterial sinusitis or complications requiring medical evaluation. This protocol supports the chronic terrain and is not a substitute for that assessment.
Note: For qualified healthcare practitioners only. This material is educational and does not replace clinical judgement, individual patient assessment, or the manufacturer's official directions and contraindications. Injectable and practitioner-administered preparations must be used only by suitably trained clinicians observing local scope-of-practice and aseptic standards.